• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » NIH agency gets new name to reflect complementary, integrative health

NIH agency gets new name to reflect complementary, integrative health

December 18, 2014
CenterWatch Staff

The NIH agency with primary responsibility for research on promising health approaches already in use by the American public has a new name—the National Center for Complementary and Integrative Health (NCCIH).

The revision from the National Center for Complementary and Alternative Medicine (NCCAM) was mandated as part of the omnibus budget measure signed by President Obama.

Large population-based surveys have found that the use of alternative medicine—unproven practices used in place of conventional medicine—is rare. Integrative health care, defined as a comprehensive, often interdisciplinary approach to treatment, prevention and health promotion that brings together complementary and conventional therapies, is more common. The use of an integrative approach to health and wellness has grown within care settings across the U.S., including hospitals, hospices and military health facilities.

“The intent of an integrative approach is to enhance overall health status, prevent disease, and alleviate debilitating symptoms such as pain and chemotherapy-induced nausea, among others. However, the scientific foundation for many complementary approaches is still being built,” said Josephine P. Briggs, M.D., director of NCCIH. “The mission of NCCIH will remain unchanged. We will continue to focus on the study of the usefulness and safety of complementary and integrative interventions, and provide the public with research-based information to guide health care decision making.”

The name change is in keeping with the center’s pre-existing congressional mandate and is aligned with the strategic plan guiding the center’s research priorities and public education activities. Public comments on a revised name were invited in May and June and indicated overall support for the change.

The center’s research priorities include the study of complementary approaches—such as spinal manipulation, meditation and massage—to manage pain and other symptoms that are not always well-addressed by conventional treatments. The center’s research also encourages self-care methods that support healthier lifestyles and uncovers potential usefulness and safety issues of natural products. The practices and products studied by the center are prioritized by four guiding principles: scientific promise, amenability to be studied using the highest quality research methods, use by the American public and the potential impact on public health.

In 1992, the Office of Alternative Medicine (OAM) was established within the Office of the Director, NIH, to facilitate study and evaluation of complementary and alternative medical practices and to disseminate the resulting information to the public. In 1998, NCCAM was established by Congress, elevating OAM to the status of an NIH center.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • Revamp-360x240.png

    Califf Calls for Major Evidence Generation Revamp, Experts’ Opinions Differ

  • AskTheExpertsGreen-360x240.png

    Ask the Experts: Managing Investigational Products

  • SurveywBlueBackground-360x240.png

    Survey Outlines Site Challenges, Successes on Diversity

  • PatientCentricity-360x240.png

    Site Spotlight: DM Clinical Shows Patient Centricity Doesn’t Have to Break the Bank

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing